ArticleBMC infectious diseases2023

Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO).

Jessica J Tuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.